Sandy Draper

Stock Analyst at Guggenheim

(3.37)
# 824
Out of 4,667 analysts
125
Total ratings
52.69%
Success rate
14.3%
Average return

Stocks Rated by Sandy Draper

Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464$432
Current: $326.09
Upside: +32.48%
Accolade
Jun 28, 2024
Maintains: Buy
Price Target: $13$6
Current: $3.56
Upside: +68.54%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $194.38
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $187.90
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36$34
Current: $11.31
Upside: +200.62%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8$10
Current: $4.31
Upside: +132.02%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $49.90
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3$2
Current: $0.13
Upside: +1,412.86%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271$263
Current: $203.67
Upside: +29.13%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21$30
Current: $1.67
Upside: +1,696.41%
Maintains: Buy
Price Target: $89$94
Current: $102.96
Upside: -8.70%
Upgrades: Neutral
Price Target: n/a
Current: $9.00
Upside: -
Maintains: Buy
Price Target: $36$51
Current: $20.79
Upside: +145.31%
Maintains: Buy
Price Target: $143$129
Current: $167.88
Upside: -23.16%
Maintains: Buy
Price Target: $84$55
Current: $39.20
Upside: +40.31%
Maintains: Buy
Price Target: $226$168
Current: $52.70
Upside: +218.79%
Initiates: Hold
Price Target: $12
Current: $21.79
Upside: -44.93%
Initiates: Buy
Price Target: $180
Current: $0.73
Upside: +24,557.53%
Maintains: Hold
Price Target: $33$38
Current: $22.23
Upside: +70.94%
Initiates: Buy
Price Target: $50
Current: $3.46
Upside: +1,345.09%
Initiates: Buy
Price Target: $65
Current: $15.36
Upside: +323.18%
Maintains: Buy
Price Target: $30$36
Current: $7.36
Upside: +389.13%
Maintains: Buy
Price Target: $175$167
Current: $210.63
Upside: -20.71%
Upgrades: Buy
Price Target: n/a
Current: $1.33
Upside: -
Initiates: Buy
Price Target: $63
Current: $16.92
Upside: +272.34%